Form 4: Bicycle Therapeutics COO Sells Shares
Insider Transaction Report
Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics PLC, reported transactions involving the sale of ordinary shares.
Summary
- Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics PLC, engaged in several transactions involving the company's ordinary shares.
- On July 2, 2026, 1,036 shares were sold at a weighted average price of $4.27 to cover statutory tax withholding obligations related to RSU vesting.
- On July 6, 2026, an additional 43 shares were sold at a weighted average price of $4.31, also to cover tax withholding.
- On the same day, July 6, 2026, 333 shares were sold at a price of $4.34 as part of a Rule 10b5-1 trading plan adopted on March 27, 2025.
- Following these transactions, Perry beneficially owns 91,052 ordinary shares.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to insider selling, though the explanations for the sales (tax withholding and 10b5-1 plan) mitigate significant concern.
Negatives
- The COO sold a total of 1,412 shares across multiple transactions.
Risks
- The sale of shares by a key executive could be perceived negatively by the market, although a portion was to cover tax obligations and another part was under a pre-arranged trading plan.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which details past transactions.
Industry Context
StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by investors. While these sales are attributed to tax obligations and a pre-established trading plan, any significant selling by executives can influence market perception.
Stakeholder Impact
- Shareholders may view insider sales with caution, although the stated reasons for these transactions are standard and mitigate potential negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/27/2025 | Date of adoption of the Rule 10b5-1 trading plan. |
| 07/02/2026 | Earliest transaction date reported; sale of 1,036 shares for tax withholding. |
| 07/06/2026 | Date of additional sales of 43 shares for tax withholding and 333 shares under a 10b5-1 plan. |
Keywords
Bicycle Therapeutics, BCYC, Form 4, Insider Trading, Stock Sale, COO, Jennifer Scott Perry, RSU Vesting, Tax Withholding, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.